| About SMA |
| Annual Scientific Assembly |
| Medallion Level CME/CE |
| Practice Management |
| Personal & Professional Financial Services |
| SMAtips |
| Member Services |
| Physicians In Training |
| SMA Community |
| Site Map |
|
| |
|
Daily Schedule
Denotes Optional ISCD Courses
Thursday, February 19, 2009
7:00 am -
5:15 pm |
ISCD Bone Densitometry Course, Day 1
This course is optional and additional fees apply. You must be registered for SMA’s 12th Annual Conference on Osteoporosis to attend this course. Technologists end at 4:45; Clinicians end at 5:15 pm. |
|
| 7:00 |
Registration and Continental Breakfast |
|
| 7:30 |
General Session – Combined Clinician and Technologist Courses |
|
| 10:30 |
Refreshment Break |
|
| 10:45 |
Clinician and Technologist Courses Divide to Separate Rooms |
|
| 10:45 - 4:45 |
Technologist Course Lectures |
|
| 10:45 - 5:15 |
Clinician Course Lectures |
|
SMA 12th Annual Conference on Osteoporosis |
| 5:30 - 6:30 pm |
Welcome and Wine Tasting Reception
All meeting attendees, spouses, and guests are welcome to attend. Hosted by the Amelia Island Plantation. |
|
| 6:30 pm |
Plenary Session: Understanding Bone Turnover
Recognize bone turnover, the roles of the various bone cells and the factors modulating osteoclastic and osteoblastic activity in order to better understand the nature of osteoporosis, and the mechanism of action, impact and limitations of medications available to treat osteoporosis.
|
|
| 7:30 pm |
Adjourn |
|
| 7:30 - 10:00 pm |
Clinical Insights Into Osteoporosis: An Interactive Scientific Exhibit |
|
Friday, February 20
| 7:30 |
Continental Breakfast |
|
| 8:00 |
The Diagnosis of Osteoporosis
Review the usefulness and limitations of the various diagnostic techniques available, including the WHO – FRAX model; DXA pitfalls to avoid; iatrogenically induced osteoporosis and secondary osteoporosis. |
Ronald C. Hamdy, MD |
| 8:45 |
Using the WHO - FRAX Model to Develop a Management Strategy
Recognize the usefulness and limitations of the WHO – FRAX model to develop a management strategy tailored to the individual patient with a low bone mass. |
E. Michael Lewiecki, MD |
| 9:30 |
Hyperparathyroidism
Review of the clinical presentation, diagnosis and management of primary and secondary hyperparathyroidism. |
|
| 10:30 |
BREAK – VISIT EXHIBITS |
|
| 11:00 |
Low Bone Mass/Osteoporosis in Men
A discussion of the causes of low bone mass in premenopausal women, its diagnostic approach and management. |
E. Michael Lewiecki, MD |
| 11:45 |
Nutrition & Osteoporosis – More Than Just Calcium and Vitamin D
Recognize the impact of diet on bone health, including calcium, vitamin D, protein, sodium, magnesium, vitamin B12, protein, caffeine, phosphoric acid, and selected nutritional supplements often included in over-the-counter preparations. |
Sarah Morgan, RD, MD |
| 1:00 |
SMA Conference Adjourns |
|
| 12:30 - 6:45 pm |
ISCD Bone Densitometry Course, Day 2
This course is only open to those who are registered for both days. |
|
| 12:30 pm |
Sign-in and Box Lunch for those registered for ISCD Bone Densitometry Course/Exam, Day 2 |
|
| 1:00-5:00 |
Technologist Course Lectures |
|
| 1:00-4:30 |
Clinician Course Lectures |
|
| 4:30-6:45 |
Clinician Exam |
|
Saturday, February 21
| 7:30 am |
Continental Breakfast |
|
| 8:00 |
Treatment Modalities
An evidence-based review of the fracture risk reduction, uses, limitations and adverse effect profile of available medications for osteoporosis. |
|
| 8:00 |
Calcium/vitamin D |
Ronald C. Hamdy, MD |
| 8:15 |
Alendronate |
JoAnn V. Pinkerton, MD |
| 8:30 |
Risedronate |
E. Michael Lewiecki, MD |
| 8:45 |
Ibandronate |
Sarah Morgan, RD, MD |
| 9:00 |
Zoledronate |
Ronald C. Hamdy, MD |
| 9:15 |
Raloxifene/Estrogen |
JoAnn V. Pinkerton, MD |
| 9:30 |
Teriparatide |
E. Michael Lewiecki, MD |
| 9:45 |
Denosunab |
Sarah Morgan, RD, MD |
| 10:00 |
Panel Discussion |
All Faculty |
| 10:30 |
BREAK |
|
| 11:00 |
HRT – Have We Come Full Circle?
Define the uses and limitations of HRT in post-menopausal women; ppreciate that some of the potential adverse effects of HRT may be related to the time lag between the menopause and the initiation of this therapy; Select appropriate candidates for HRT and the optimum formulation used, including estrogen preparation, dosage, combination versus unopposed estrogen, oral versus transdermal versus topical preparations, and duration of therapy; Develop a management strategy tailored to the needs of the individual post-menopausal woman, including initial assessment, follow-up, and what to expect/do when the therapy is discontinued. |
JoAnn V. Pinkerton, MD |
| 12:15 |
BOXED LUNCH |
|
| 12:30 |
Vertebral Compression Fractures
Appreciate the impact of vertebral compression fractures, even the clinically asymptomatic ones. Develop a treatment program tailored to individual patients to manage acute symptomatic vertebral fractures, including vertebroplast/kyphoplasty. |
E. Michael Lewiecki, MD |
| 1:15 |
Osteoporosis and Gastro-intestinal Diseases: Maintaining Bone Mass after Bariatric Surgery
Understand the various gastro-intestinal disease that may predispose to osteoporosis and how to mange osteoporosis in patients with GI diseases including peptic ulcer disease, Crohn’s disease, and malabsorption syndromes. Appreciate the unique bone problems affecting patients who have undergone bariatric surgery, how to prevent and treat them. |
Sarah Morgan, RD, MD |
| 2:15 |
ADJOURN |
|
Sunday, February 22
| 7:30 am |
Continental Breakfast |
|
| 8:00 |
Review of Pre-test Questions with Discussion |
Ronald C. Hamdy, MD |
| 8:15 |
Case Presentations
Through a series of case studies, develop a management strategy tailored to the individual needs of patients with osteoporosis. This session will help crystallize the information presented throughout the course. |
Ronald C. Hamdy, MD |
| 10:30 |
ADJOURN |
|
Denotes Optional ISCD Courses
|
|
|
|
